Related Experiment Video
Updated: Apr 29, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Lamin A/C mutations in dilated cardiomyopathy
Frédérique Tesson1, Michal Saj, Musfira Mohamed Uvaize
1Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada. ftesson@uOttawa.ca.
Insights
Mutations in the lamin A/C gene (LMNA) cause dilated cardiomyopathy (DCM), a leading cause of heart failure. This review covers LMNA mutation phenotypes, disease models, and pathogenesis theories for laminopathies.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) is a primary cause of heart failure and heart transplantation.
- Mutations in approximately 60 genes are linked to DCM, with mutations in the lamin A/C gene (LMNA) accounting for about 6% of cases.
- LMNA encodes type-V intermediate filaments crucial for nuclear membrane structure, chromatin organization, and gene expression.
Purpose of the Study:
- To explore the diverse phenotypes associated with LMNA-caused DCM.
- To review findings from cellular and animal models of DCM.
- To discuss current theories on the pathogenesis of laminopathies.
Main Methods:
- Literature review of phenotypes in LMNA-mutation patients.
- Analysis of results from cellular and animal models of DCM.
- Synthesis of prevailing theories on laminopathy pathogenesis.
Main Results:
- LMNA mutations manifest in various cellular and physiological phenotypes.
- Disease models provide insights into the mechanisms of LMNA-related cardiomyopathies.
- Understanding pathogenesis is key to developing therapeutic strategies.
Conclusions:
- LMNA mutations represent a significant genetic cause of DCM with diverse clinical presentations.
- Cellular and animal models are instrumental in elucidating disease mechanisms.
- Further research into laminopathy pathogenesis may lead to targeted treatments for DCM.
Abstract:
Dilated cardiomyopathy (DCM) is one of the leading causes of heart failure and heart transplant. Mutations in 60 genes have been associated with DCM. Approximately 6% of all DCM cases are caused by mutations in the lamin A/C gene (LMNA). LMNA codes for type-V intermediate filaments that support the structure of the nuclear membrane and are involved in chromatin structure and gene expression. Most LMNA mutations result in striated muscle diseases while the rest affects the adipose tissue, peripheral nervous system, multiple tissues or lead to progeroid syndromes/overlapping syndromes. Patients with LMNA mutations exhibit a variety of cellular and physiological phenotypes. This paper explores the current phenotypes observed in LMNA-caused DCM, the results and implications of the cellular and animal models of DCM and the prevailing theories on the pathogenesis of laminopathies.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mitral Valve Prolapse I: Introduction

